Matches in SemOpenAlex for { <https://semopenalex.org/work/W3215184257> ?p ?o ?g. }
- W3215184257 endingPage "55" @default.
- W3215184257 startingPage "46" @default.
- W3215184257 abstract "There is no global agreement on how to best determine pregnancy of unknown location viability and location using biomarkers. Measurements of progesterone and β human chorionic gonadotropin (βhCG) are still used in clinical practice to exclude the possibility of a viable intrauterine pregnancy (VIUP). We evaluate the predictive value of progesterone, βhCG, and βhCG ratio cut-off levels to exclude a VIUP in women with a pregnancy of unknown location.This was a secondary analysis of prospective multicenter study data of consecutive women with a pregnancy of unknown location between January 2015 and 2017 collected from dedicated early pregnancy assessment units of eight hospitals. Single progesterone and serial βhCG measurements were taken. Women were followed up until final pregnancy outcome between 11 and 14 weeks of gestation was confirmed using transvaginal ultrasonography: (1) VIUP, (2) non-viable intrauterine pregnancy or failed pregnancy of unknown location, and (3) ectopic pregnancy or persisting pregnancy of unknown location. The predictive value of cut-off levels for ruling out VIUP were evaluated across a range of values likely to be encountered clinically for progesterone, βhCG, and βhCG ratio.Data from 2507 of 3272 (76.6%) women were suitable for analysis. All had data for βhCG levels, 2248 (89.7%) had progesterone levels, and 1809 (72.2%) had βhCG ratio. The likelihood of viability falls with the progesterone level. Although the median progesterone level associated with viability was 59 nmol/L, VIUP were identified with levels as low as 5 nmol/L. No single βhCG cut-off reliably ruled out the presence of viability with certainty, even when the level was more than 3000 IU/L, there were 39/358 (11%) women who had a VIUP. The probability of viability decreases with the βhCG ratio. Although the median βhCG ratio associated with viability was 2.26, VIUP were identified with ratios as low as 1.02. A progesterone level below 2 nmol/L and βhCG ratio below 0.87 were unlikely to be associated with viability but were not definitive when considering multiple imputation.Cut-off levels for βhCG, βhCG ratio, and progesterone are not safe to be used clinically to exclude viability in early pregnancy. Although βhCG ratio and progesterone have slightly better performance in comparison, single βhCG used in this manner is highly unreliable." @default.
- W3215184257 created "2021-12-06" @default.
- W3215184257 creator A5002144411 @default.
- W3215184257 creator A5012856345 @default.
- W3215184257 creator A5014102107 @default.
- W3215184257 creator A5014869718 @default.
- W3215184257 creator A5014947801 @default.
- W3215184257 creator A5016685094 @default.
- W3215184257 creator A5027201749 @default.
- W3215184257 creator A5033777232 @default.
- W3215184257 creator A5042504160 @default.
- W3215184257 creator A5044514469 @default.
- W3215184257 creator A5049279274 @default.
- W3215184257 creator A5052281499 @default.
- W3215184257 creator A5060235264 @default.
- W3215184257 creator A5073475634 @default.
- W3215184257 creator A5081124265 @default.
- W3215184257 creator A5086320066 @default.
- W3215184257 creator A5090053987 @default.
- W3215184257 creator A5090442311 @default.
- W3215184257 date "2021-11-24" @default.
- W3215184257 modified "2023-09-24" @default.
- W3215184257 title "Evaluating cut‐off levels for progesterone, β human chorionic gonadotropin and β human chorionic gonadotropin ratio to exclude pregnancy viability in women with a pregnancy of unknown location: A prospective multicenter cohort study" @default.
- W3215184257 cites W1853170314 @default.
- W3215184257 cites W1981076220 @default.
- W3215184257 cites W1988641909 @default.
- W3215184257 cites W2041133683 @default.
- W3215184257 cites W2043619880 @default.
- W3215184257 cites W2065974896 @default.
- W3215184257 cites W2084843096 @default.
- W3215184257 cites W2089640775 @default.
- W3215184257 cites W2104718650 @default.
- W3215184257 cites W2107537280 @default.
- W3215184257 cites W2110396938 @default.
- W3215184257 cites W2115709314 @default.
- W3215184257 cites W2133988102 @default.
- W3215184257 cites W2140716217 @default.
- W3215184257 cites W2155715913 @default.
- W3215184257 cites W2159410320 @default.
- W3215184257 cites W2163360475 @default.
- W3215184257 cites W2170346303 @default.
- W3215184257 cites W2285802659 @default.
- W3215184257 cites W2296831586 @default.
- W3215184257 cites W2364991362 @default.
- W3215184257 cites W2732564428 @default.
- W3215184257 cites W2888406543 @default.
- W3215184257 cites W2965226443 @default.
- W3215184257 cites W2981142573 @default.
- W3215184257 cites W2988417862 @default.
- W3215184257 cites W3020992444 @default.
- W3215184257 cites W3087205353 @default.
- W3215184257 cites W4235266600 @default.
- W3215184257 cites W4255895129 @default.
- W3215184257 doi "https://doi.org/10.1111/aogs.14295" @default.
- W3215184257 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34817062" @default.
- W3215184257 hasPublicationYear "2021" @default.
- W3215184257 type Work @default.
- W3215184257 sameAs 3215184257 @default.
- W3215184257 citedByCount "1" @default.
- W3215184257 countsByYear W32151842572023 @default.
- W3215184257 crossrefType "journal-article" @default.
- W3215184257 hasAuthorship W3215184257A5002144411 @default.
- W3215184257 hasAuthorship W3215184257A5012856345 @default.
- W3215184257 hasAuthorship W3215184257A5014102107 @default.
- W3215184257 hasAuthorship W3215184257A5014869718 @default.
- W3215184257 hasAuthorship W3215184257A5014947801 @default.
- W3215184257 hasAuthorship W3215184257A5016685094 @default.
- W3215184257 hasAuthorship W3215184257A5027201749 @default.
- W3215184257 hasAuthorship W3215184257A5033777232 @default.
- W3215184257 hasAuthorship W3215184257A5042504160 @default.
- W3215184257 hasAuthorship W3215184257A5044514469 @default.
- W3215184257 hasAuthorship W3215184257A5049279274 @default.
- W3215184257 hasAuthorship W3215184257A5052281499 @default.
- W3215184257 hasAuthorship W3215184257A5060235264 @default.
- W3215184257 hasAuthorship W3215184257A5073475634 @default.
- W3215184257 hasAuthorship W3215184257A5081124265 @default.
- W3215184257 hasAuthorship W3215184257A5086320066 @default.
- W3215184257 hasAuthorship W3215184257A5090053987 @default.
- W3215184257 hasAuthorship W3215184257A5090442311 @default.
- W3215184257 hasBestOaLocation W32151842571 @default.
- W3215184257 hasConcept C126322002 @default.
- W3215184257 hasConcept C131872663 @default.
- W3215184257 hasConcept C134018914 @default.
- W3215184257 hasConcept C188816634 @default.
- W3215184257 hasConcept C2775948956 @default.
- W3215184257 hasConcept C2776018949 @default.
- W3215184257 hasConcept C2778782382 @default.
- W3215184257 hasConcept C2779234561 @default.
- W3215184257 hasConcept C29456083 @default.
- W3215184257 hasConcept C46973012 @default.
- W3215184257 hasConcept C54355233 @default.
- W3215184257 hasConcept C71315377 @default.
- W3215184257 hasConcept C71924100 @default.
- W3215184257 hasConcept C86803240 @default.
- W3215184257 hasConceptScore W3215184257C126322002 @default.
- W3215184257 hasConceptScore W3215184257C131872663 @default.
- W3215184257 hasConceptScore W3215184257C134018914 @default.
- W3215184257 hasConceptScore W3215184257C188816634 @default.